We are live on ! Find out more
AICPI

ABG Innovation Capital Partners III Portfolio holdings

AUM $64.5K
1-Year Est. Return 1.01%
This Fund
S&P 500
This Quarter Est. Return
-7.62%
1 Year Est. Return
+1.01%
3 Year Est. Return
+5.56%
5 Year Est. Return
-85.52%
10 Year Est. Return
–
AUM
$1.46M
AUM Growth
-$266K
Cap. Flow
-$93K
Cap. Flow %
-6.36%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
LUNG icon
Pulmonx
LUNG
+$93K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYBX
1
DELISTED
Synlogic
SYBX
$494K 33.77%
13,727
– –
GNCA
2
DELISTED
Genocea Biosciences, Inc.
GNCA
$469K 32.06%
375,000
– –
WHWK
3
Whitehawk Therapeutics
WHWK
$201M
$453K 30.96%
26,666
– –
ACGN
4
DELISTED
Aceragen Inc
ACGN
$28K 1.91%
3,312
– –
NBRV
5
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$19K 1.3%
1,834
– –
LUNG icon
6
Pulmonx
LUNG
$83.6M
– –
-2,901
Closed -$93K

Similar funds

FFVM
Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return
SNN
Shen Neil Nanpeng $36.3K AUM 179.45% 1-Year Est. Return
AC
Antara Capital New York $30.2K AUM 5.24% 1-Year Est. Return
MI
Motiv8 Investments Port St. Lucie, Florida $183K AUM 15.06% 1-Year Est. Return
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
NA
Newport Asia San Francisco, California $2.21M AUM
IVSFI
IA Venture Strategies Fund II New York $4.08M AUM 174.71% 1-Year Est. Return

ABG Innovation Capital Partners III's Q1 2022 Portfolio in Review

As of Q1 2022, ABG Innovation Capital Partners III held 6 positions worth $1.46M, down 15% from $1.73M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

ABG Innovation Capital Partners III withdrew a net $93K in Q1 2022, closing 1 position. Its most notable exit was Pulmonx, an estimated $93K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • ABG Innovation Capital Partners III fully exited Pulmonx in Q1 2022, selling an estimated $93K.
  • ABG Innovation Capital Partners III's ten largest holdings make up 100% of its $1.46M portfolio in Q1 2022.
  • ABG Innovation Capital Partners III opened 0 new positions and closed 1 in Q1 2022.
  • ABG Innovation Capital Partners III's portfolio value fell 15% quarter-over-quarter to $1.46M.

Based on ABG Innovation Capital Partners III's 13F filing for Q1 2022, filed 16 May 2022.